Octave Bioscience Inc: Valuation, Funding & Investors
Octave Bioscience, Inc. is a commercial stage precision care company specializing in biomarker-driven solutions for neurodegenerative diseases, with a primary focus on Multiple Sclerosis and Parkinson's Disease. The company offers comprehensive testing solutions that provide objective and actionable insights to enhance disease monitoring, treatment decisions, and patient outcomes.
Leadership & Board
- Current Number of Employees
- 99
- Current LinkedIn Followers
- 30,574
Latest Estimated Valuation
- Total Amount Raised
- $36M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $36M
- Latest Funding Round
- Series C
Company Momentum Positive
Octave Bioscience Inc LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Octave Bioscience Inc had 99 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Octave Bioscience Inc had 30,574 followers as of October 26, 2026. The number of followers increased by 5 (0.02%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Sep 04, 2025 | Series C | $35.60M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| S32 | Series C |
| Intermountain Ventures | Series C |
| Blue Venture Fund | Series C |
| Casdin Capital | Series C |
| Byers Capital | Series C |
| Northpond Ventures | Series C |
| Merck Global Health Innovation Fund | Series C |
| Novartis | Series C |
Similar Companies
A snapshot of private companies similar to Octave Bioscience Inc, helping you discover and navigate related company profiles.
Related News and Analysis
